BIT
Click for more information
0.00% 3.4¢ biotron limited

Ann: BIT225 Phase 2 HIV Efficacy Trial Meets Primary Objectives, page-41

  1. J8
    14,545 Posts.
    lightbulb Created with Sketch. 822
    clock Created with Sketch.
    19/06/24
    10:56
    Post #: 74385546
    As expected. Yawn. Ho-hum etc.

    Imo they should be doing 100mg twice a day. But that doesn’t suit deals… a pill a day is req’d. Mr Market knows, believers don’t.

    DYOR but this confirms that 200mg makes people feel sick. Yeah yeah… I know you can quote various bulldust reports - but it always has. No future here imho.

    COVID ??? Still a maybe…. but.

    And … no cash. Mmmmm
    Last edited by J8: 19/06/24
    BIT Price at posting: 5.5¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch. 1  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

ABY Adore Beauty FY24 revenues up 7.4% YoY to $196M
right-arrow Created with Sketch.
AMI First stope ore could be pushed back to Q2 FY25 due to flood-like event: Aurelia
right-arrow Created with Sketch.
EVN Evolution shares up 3% on quarterly results for June showing rise in gold production
right-arrow Created with Sketch.
DMP Domino's locks in biggest faller status on Thursday as it closes stores in Asia, Europe
right-arrow Created with Sketch.
NRX Noronex joins forces with South32 to look for copper in Namibia
right-arrow Created with Sketch.
NEWS Talking Australia's very competitive property landscape: Realty Talks
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.4¢ 		Change
0.000(0.00%) 		Mkt cap ! $30.67M
Open High Low Value Volume
3.3¢ 3.5¢ 3.3¢ $12.66K 367.6K

Buyers (Bids)

No. Vol. Price($)
1 155931 3.4¢
 

Sellers (Offers)

Price($) Vol. No.
3.6¢ 113208 2
View Market Depth
Last trade - 16.10pm 22/07/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.